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Ablation of IL-33 Suppresses Th2 Responses but Is
Accompanied by Sustained Mucus Obstruction in the Scnn1b
Transgenic Mouse Model
Brandon W. Lewis,*,1 Thao Vo,*,1 Ishita Choudhary,*,1 Allison Kidder,* Chandra Bathula,*
Camille Ehre,† Nobuko Wakamatsu,‡ Sonika Patial,* and Yogesh Saini*
Cystic fibrosis is characterized by dehydration of the airway surface liquid layer with persistent mucus obstruction. Th2 immune
responses are often manifested as increased mucous cell density (mucous cell metaplasia) associated with mucus obstruction. IL-33
is a known inducer of Th2 immune responses, but its roles in mucus obstruction and related phenotypes in a cystic fibrosis–like
lung disease model (i.e., Scnn1b-Tg–positive [Tg+]) mouse, remain unclear. Accordingly, IL-33 knockout (IL-33KO) Tg+ mice were
examined and compared with IL-33 heterozygous (IL-33HET) Tg+ mice. As compared with IL-33HET/Tg+ mice, IL-33KO/Tg+ mice
had complete absence of bronchoalveolar lavage fluid eosinophilia, accompanied with significant reduction in bronchoalveolar
lavage fluid concentration of IL-5, a cytokine associated with eosinophil differentiation and recruitment, and IL-4, a major
Th2 cytokine. As compared with IL-33HET/Tg+ mice, IL-33KO/Tg+ mice had significantly reduced levels of Th2-associated gene
signatures (Slc26a4, Clca1, Retnla, and Chi3l4), along with complete loss of intracellular mucopolysaccharide staining in the
airway epithelium. As compared with IL-33HET/Tg+ mice, although the IL-33KO/Tg+ mice had significantly reduced levels of
MUC5AC protein expression, they showed no reduction in the degree of mucus obstruction, MUC5B protein expression, bacterial
burden, and neonatal mortality. Interestingly, the histological features, including subepithelial airway inflammation and alveolar
space enlargement, were somewhat exaggerated in IL-33KO/Tg+ mice compared with IL-33HET/Tg+ mice. Taken together, our
data indicate that although IL-33 modulates Th2 inflammatory responses and MUC5AC protein production, mucus obstruction is
not dependent on IL-33. The Journal of Immunology, 2020, 204: 1650–1660.
A
irway mucosal surfaces are lined by a thin layer of liquid
(i.e., the airway surface liquid [ASL]) consisting of water,
ions, proteins, and macromolecules, including mucin
glycoproteins (1). Optimal solid contents of the ASL layer are
essential for the proper functioning of the mucociliary appa-
ratus that propels the mucus layer with entrapped airborne
particles toward the epiglottis (1). The dysfunction of the cystic
fibrosis (CF) transmembrane conductance regulator in CF airways
induces ionic imbalance that results in dehydration of the ASL
layer and an associated increase in solid contents in the ASL layer
and consistent mucus obstruction (2, 3). In addition to ASL
dehydration, mucoinflammatory responses (i.e., excessive mucin
production accompanied with increased inflammatory cell density
and cellular debris) may also result in increased ASL solid contents
and, ultimately, contribute to the mucus obstruction. Therefore, it is
unclear whether the CF-like muco-obstructive phenotype is due to
ASL dehydration alone or mucoinflammatory responses alone or
a combination of both. Whereas investigating these scenarios is
challenging in human CF patients, the Scnn1b transgenic–positive
(Tg+) mouse is an ideal model for experimental testing, as it
manifests CF-like lung disease.
The Tg+ mouse model overexpresses the sodium channel
non–voltage gated 1 b subunit (Scnn1b) in the airway epithelial
cells that induces epithelial water hyperabsorption, resulting in
a phenocopy of CF-like ASL dehydration (4, 5). The Tg+ mice
exhibit robust Th2 mucoinflammatory airway pathology with marked
mucous cell metaplasia (MCM) and increased molecular markers
of Th2 inflammation (5–7). These responses are associated with
mucus obstruction that provides a fertile nidus for bacterial col-
onization (5). IL-33 has been shown to be a potent stimulator of
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histological sections stained with H&E were used to evaluate histopath-
ological changes. To evaluate mucus obstruction and MCM, histological slides
were stained with Alcian blue–periodic acid Schiff (AB-PAS). Mucous cell
density (number of mucous cells per millimeter of basement membrane) was
used as a quantitative parameter to evaluate MCM, using 340 objective of
Nikon Eclipse Ci light microscope with camera attachment (Nikon Digital
Sight DSFi2). Airway epithelial cells (at least 50 cells) and mucous cells,
distinguished by presence of AB-PAS staining, were counted.
Gene expression analyses
Total RNAwas extracted and analyzed for quantity and purity as described
previously (9). cDNA generation and RT-PCR were done to assess the gene
expression signals of selected genes Slc26a4, Clca1, Retnla, Chi3l4,
Muc5b, and Muc5ac, as described previously (9).
Mucins agarose gel electrophoresis and Western blotting
BALF mucin electrophoresis and Western blotting were performed using a
slightly modified protocol, as described previously (14). Briefly, BALFmucins
were denatured with urea (6 M). Equal volumes (50 ml per well) of BALF
samples were electrophoresed on 1% agarose gel (at 80 V for 90 min) and
vacuum blotted onto nitrocellulose membranes with 43 sodium saline citrate
buffer for 2 h at 250 mBar pressure. After transfer, the nitrocellulose
membrane was blocked with blocking buffer (LI-COR Biosciences, Lincoln,
NE) for 1 h at room temperature, followed by primary Ab incubation
(overnight at 4˚C) with rabbit polyclonal Abs against MUC5B (UNC223;
University of North Carolina, Chapel Hill, NC) and mouse mAbs against
MUC5AC (AB3649; Abcam, Cambridge, MA). After washing, the mem-
brane was probed with IRDye 680RD Goat anti-Rabbit and IRDye 800CW
Goat anti-Mouse IgG (LI-COR Biosciences) secondary Abs, each diluted to
1:5000 in blocking buffer. After 1 h of incubation at room temperature, the
membrane was analyzed by the Odyssey CLx Infrared Imaging System
(LI-COR Biosciences). The band intensity was measured using Image J
software (National Institutes of Health).
RNAScope (RNA in situ hybridization)
To assess the distribution and relative abundance of Muc5b and Muc5ac
transcripts, in situ hybridization was performed on paraffin-embedded airway
sections using Advanced Cell Diagnostics (ACD) proprietary RNAScope
Technology (ACD, Newark, CA). Predesigned transcript-specific probes
were used to hybridize Muc5b and Muc5ac transcripts in the airway
sections, and an RNAScope 2.5 HD Duplex Assay Kit (ACD) was used
to amplify the transcript signals. Muc5b and Muc5ac amplification signals
were detected as green and red staining, respectively.
Mean linear intercept measurements
Briefly, two different lung sections per mousewere imaged at 103magnification
using a Nikon scope (Nikon) with camera attachment (Nikon Digital Sight
DSFi2). Images were loaded onto Image J software and converted to bi-
nary. Horizontal grid lines were superimposed on the lung section image.
Using line drawing software, lines were drawn along gridlines and mea-
sured. Intercepts were considered as points of contact between the drawn
line and alveolar septi. Mean linear intercepts (MLI) were determined by
dividing the sum of the length of all drawn lines (micrometers) by the sum
of the total intercepts between alveolar septi and drawn lines (15).
Statistical analyses
One-way ANOVA followed by Tukey post hoc test for multiple comparisons
was used to determine significant differences among groups. Measurements
from two groups were compared using Student t test assuming unequal
variance. All data were expressed as mean 6 SEM. A p value , 0.05 was
considered statistically significant. Statistical analyses were performed
using GraphPad Prism 7.0 (GraphPad Software, La Jolla, CA).
Results
IL-33 contents are elevated in the BALF and lung tissue of
Tg+ mice
To identify the age at which IL-33 is released into the airspaces of
Tg+ mice, IL-33 contents were estimated in BALF from WT and
Tg+ neonates (postnatal day [PND] 7) and juveniles (PND 21).
IL-33 protein was undetectable in BALF from WT as well as Tg+
neonates (Fig. 1A, left panel). Although IL-33 protein was un-
detectable in BALF from WT juveniles, the Tg+ juveniles had
significantly elevated levels of IL-33 (Fig. 1A, right panel).
Th2 inflammation (8). Our recent report identified an intriguing
association between reduced IL-33 expression and diminished Th2
mucoinflammatory responses (e.g., MCM, mucus obstruction, and
molecular markers of Th2 inflammation) (9). However, it remains
to be mechanistically tested whether the germline deletion of
IL-33 prevents Th2 responses and mucus obstruction in Tg+ mice.
In this study, we hypothesized that IL-33 is essential for Th2
inflammatory responses that contribute to the mucus obstruction in
the airways of Tg+ mice. To test this hypothesis, IL-33 knockout
Tg+ (IL-33KO/Tg+) mice were generated and compared with
IL-33 heterozygous Tg+ (IL-33HET/Tg+) mice for various patho-
logical manifestations of CF-like muco-obstructive lung disease.
Specifically, the effects of IL-33 deletion on 1) inflammatory cell
recruitment, 2) levels of inflammatory mediators, 3) clearance of
spontaneous bacterial infection, 4) neonatal mortality, 5) presence of
mucous secretory cells, and 6) mucus obstruction were determined.
Importantly, we also determined the effects of IL-33 deletion on
the mRNA and protein expression levels of two major gel-forming
mucins, MUC5B and MUC5AC. The results from this study
delineate the contribution of IL-33 to the mucoinflammatory
responses in CF-like lung disease with dehydrated ASL layer.
Materials and Methods
Generation of Tg mice and animal husbandry
Tg+ mice (Tg(Scgb1a1-Scnn1b)6608Bouc/J) were procured from The 
Jackson Laboratory (Bar Harbor, ME), and IL-33 knockout (IL-33KO) 
mice were generously provided by Dr. Susumu Nakae (University of 
Tokyo, Tokyo, Japan) (10). Both of these mice strains were on C57BL/6 
background. These two strains were crossbred to generate IL-33 knockout 
Tg+ (IL-33KO/Tg+) and IL-33 heterozygous Tg+ (IL-33HET/Tg+) mice, 
and their Tg2 (wild-type [WT]) counterparts. Various genetic combina-
tions (e.g., IL-33HET/WT, IL-33KO/WT, IL-33HET/Tg+, and IL-33KO/Tg+) 
were generated by reciprocal crosses between IL-33HET/Tg+ and IL-33KO/WT 
mice, and in parallel, by reciprocal crosses between IL-33HET/WT and 
IL-33KO/Tg+ mice. Genotyping of experimental mice was performed 
by PCR as previously described for the presence of Tg+ and Il33 
(Supplemental Fig. 1) (5, 10). Mice were maintained in individually 
ventilated, hot-washed cages at the Division of Laboratory Animal Med-
icine (Louisiana State University, Baton Rouge, LA) on a 12 h dark/light 
cycle. Mice were fed regular diet and water ad libitum. All animal use 
procedures were approved by the Institutional Animal Care and Use 
Committee of Louisiana State University.
Bronchoalveolar lavage fluid analyses
Aseptically harvested bronchoalveolar lavage fluid (BALF) was serially di-
luted onto Columbia Blood Agar plates (Hardy Diagnostics, Santa Maria, CA) 
as previously described (9, 11, 12). The Columbia Blood Agar plates were 
incubated in an anaerobic candle jar for 48 h at 37˚C. Bacterial burden was 
determined by enumerating CFUs. Remaining BALF was centrifuged at 
300 3 g for 5 min. The supernatant was removed and stored at 280˚C for 
cytokine analyses. The cellular pellet was resuspended in 500 ml of PBS. 
Total cell counts were determined using a hemocytometer (Bright-Line, 
Horsham, PA). Cytospins (Cytospin 3; Thermo Scientific Shandon, Pittsburgh, 
PA) were prepared with a 200 ml cell suspension and differentially stained 
(Modified Giemsa kit; Newcomer Supply, Middleton, WI).
Analyses of BALF for cytokines
Cell-free BALF was assayed for various cytokines (Table I) using a Luminex 
xMAP-based assay (MCYTOMAG-70K) according to the manufacturer’s 
instructions (EMD Millipore, Billerica, MA). To estimate IL-33 concentration, 
cell-free BALF supernatant or lung homogenate supernatant was assayed with 
a Mouse/Rat IL-33 ELISA Kit (M3300) according to the manufacturer’s 
instructions (R&D Systems, Minneapolis, MN). In the case of tissue IL-33 
estimation assay, the right middle lobe was homogenized in 500 ml of  
radioimmunoprecipitation assay buffer containing protease inhibitors.
Histopathological analyses
Left lung lobes were formalin-fixed, paraffin embedded, sectioned, and stained 
for histopathological analyses. Histopathological parameters were compared 
by blinded board-certified pathologists (S. Patial and N. Wakamatsu) using 
a previously described semiquantitative grading strategy (13). Briefly,
To identify the cellular source of IL-33 in Tg+ lungs, we per-
formed immuno-histochemical staining for IL-33 in lung sections
from WT and Tg+ juveniles. Although IL-33 was found to be lo-
calized in the alveolar epithelial cells of both WTand Tg+ juveniles,
the IL-33 staining was remarkably intense in alveolar epithelial cells
from Tg+ juveniles (Fig. 1B). Further, the level of IL-33 protein in
the lung homogenates from WT and Tg+ mice on IL-33HET or
IL-33KO background were assessed (Fig. 1C). As compared
with IL-33HET/WT neonates and IL-33HET/WT juveniles, the total
IL-33 contents were significantly higher in both IL-33HET/Tg+
neonates (Fig. 1C, left panel) and IL-33HET/Tg+ juveniles (Fig. 1C,
right panel). As expected, IL-33 was undetected in the lung
homogenates from both IL-33KO/WT and IL-33KO/Tg+ neonates
(Fig. 1C, left panel) and juveniles (Fig. 1C, right panel).
IL-33 deletion modulates immune cell recruitment in juvenile
Tg+ airways
To determine the effect of IL-33 deletion on immune cell recruitment
into the Tg+ airspaces of juveniles, BALF samples were ana-
lyzed for alterations in the inflammatory cell counts and soluble
inflammatory mediators. The IL-33KO/WT and IL-33HET/WT mice
had a comparable number of total immune cells in their BALF
(Fig. 2A). The proportion of individual immune cells, including
macrophages, neutrophils, eosinophils, and lymphocytes, were
also comparable among IL-33KO/WT and IL-33HET/WT mice
(Fig. 2B, 2C). The IL-33HET/Tg+ mice had a significant increase
in the number of total BALF cells as a result of an increase in three
cell types (e.g., neutrophils, eosinophils, and lymphocytes) (Fig. 2B,
2C). The total cell, macrophage, neutrophil, and lymphocyte counts
in IL-33KO/Tg+ BALF were comparable to BALF cell counts ob-
tained from IL-33HET/Tg+ littermates (Fig. 2B, 2C). Nonetheless,
the eosinophilic counts were significantly lower in the IL-33KO/Tg+
BALF as compared with IL-33HET/Tg+ BALF (Fig. 2B, 2C).
To determine the effect of IL-33 deletion on chemokine levels in
Tg+ airspaces, BALF was assayed for the presence of cell-specific
chemokines. Neutrophil chemoattractants, including keratinocyte
chemoattractant (KC), MIP2, G-CSF,MIP1a, andMCP-1, were below
detection levels in IL-33HET/WT and IL-33KO/WT mice (Fig. 2D–F,
Table I). All of these cytokines were significantly elevated but
comparable to one another in BALF from IL-33HET/Tg+ and
FIGURE 1. IL-33 protein contents are elevated in the Tg+ lungs. IL-33 concentration in cell-free BALF from WT (white bar) and Tg+ (green bar)
neonates (A, left) and juveniles (A, right) (n = 5–6 per group). For IL-33 estimation in BALF, because equal volumes of BALF samples were used,
the estimated IL-33 values in picograms per milliliter were used directly. Error bars represent SEM. *p , 0.05 using Student t test. Representative
photomicrographs from lung sections showing immunolocalization of IL-33 protein (blue arrows) in WT juveniles (B) (top left and top right, higher
magnification) and Tg+ juveniles (B) (bottom left and bottom right, higher magnification). IL-33 concentration in picograms per milligram in lung homogenates
from WT (white bar) and Tg+ (green bar) neonates (C, left) and juveniles (C, right) (n = 8–11 per group). The estimated IL-33 values were normalized to
the total lung homogenate protein content. Error bars represent SEM. *p , 0.05, **p , 0.01, ****p , 0.0001 using ANOVA followed by Tukey multiple
comparison post hoc test.
IL-33KO/Tg+ mice (Fig. 2D–F, Table I). Eosinophil chemo-
attractants, IL-5 (Fig. 3A) and RANTES (Table I) were below
detection levels in IL-33HET/WT and IL-33KO/WT mice. Both
of these mediators were significantly elevated in BALF from
IL-33HET/Tg+ mice. However, IL-5 and RANTES were significantly
reduced to basal levels in IL-33KO/Tg+ mice (Fig. 3A, Table I).
Deletion of IL-33 results in diminished Th2 inflammation
markers in juvenile Tg+ airways
The Tg+ mice predominantly exhibit Th2 inflammation charac-
terized by elevated levels of eosinophils in BALF, elevated levels
of soluble mediators (e.g., IL-4 and IL-5), and elevated levels of
Th2 gene signatures Slc26a4 (pendrin), Clca1 (Gob5), Retnla (Fizz1),
and Chi3l4 (YM2) (9, 16). In agreement, as presented in the previous
section, IL-33HET/Tg+ mice had significant BALF eosinophilia
(Fig. 2B, 2C) and a concomitant increase in BALF IL-5 levels
(Fig. 3A). Both of these features were completely abolished in
IL-33KO/Tg+ juveniles (Figs. 2B, 2C, 3A). Although levels of IL-4
were at baseline in IL-33HET/WT and IL-33KO/WT juveniles, the
IL-33HET/Tg+ juveniles had significantly elevated BALF IL-4
levels (Fig. 3B). The BALF from IL-33KO/Tg+ juveniles had signifi-
cant reduction in IL-4 contents to baseline levels (Fig. 3B).
Th2 inflammation-associated gene signatures were assessed in the
total lung RNA preparations. In the absence of Scnn1b transgene, the
IL-33HET as well as IL-33KO juveniles had baseline levels of ex-
pression of four Th2 inflammation-associated genes [e.g., Slc26a4
(Fig. 3C), Clca1 (Fig. 3D), Retnla (Fig. 3E), and Chi3l4 (Fig. 3F)].
Although the levels of all four genes were significantly elevated
in IL-33HET/Tg+ lungs, their expression levels were significantly
reduced to the baseline level in IL-33KO/Tg+ mice (Fig. 3C–F).
FIGURE 2. IL-33 deficiency alters immune cell recruitment. (A) Total cell counts in BALF from IL-33HET/WT (white bar), IL-33KO/WT (blue bar),
IL-33HET/Tg+ (green bar), and IL-33KO/Tg+ juveniles (red bar) (n = 15–26 per group). (B) Differential cell counts (left) and relative percentages (right)
are shown as stacked bar graphs (macrophages [red], neutrophils [blue], eosinophils [green], and lymphocytes [black]). Error bars represent SEM.
Significant differences in numbers or proportions of different cell types are indicated by horizontal lines of cell-specific colors (i.e., macrophages [red line],
neutrophils [blue line], eosinophils [green line], and lymphocytes [black line]). (C) Representative photomicrographs of BALF cytospins from IL-33HET/WT,
IL-33KO/WT, IL-33HET/Tg+, and IL-33KO/Tg+ juveniles. Macrophages (red arrow), neutrophils (blue arrow), eosinophils (green arrow), and lymphocytes
(black arrow) are shown. BALF cytokine levels (picograms per milliliter) of MIP2 (D), KC (E), and G-CSF (F), in cell-free BALF from IL-33HET/WT (white
bar), IL-33KO/WT (blue bar), IL-33HET/Tg+ (green bar), IL-33KO/Tg+ juveniles (red bar). Error bars represent SEM. *p , 0.05, **p , 0.01, ***p , 0.001,
****p , 0.0001 using ANOVA followed by Tukey multiple comparison post hoc test. MIP2, macrophage inflammatory protein-2.
IL-33 deletion results in significant reduction in airway mucous
cell density but without amelioration of muco-obstructive
phenotype of Tg+ juveniles
To determine the effect of IL-33 deletion on mucus obstruction,
we analyzed the airway luminal contents in AB-PAS–stained lung
sections from WT and Tg+ mice on the IL-33HET and IL-33KO
background. Although there was no sign of mucus plugging in
IL-33HET/WT as well as IL-33KO/WT mice, the IL-33HET/Tg+
mice had marked mucus obstruction (Fig. 4A). Contrary to our ex-
pectation, the degree of mucus obstruction was significantly increased
in IL-33KO/Tg+ mice versus IL-33HET/Tg+ mice (Fig. 4A). This
quantitative scoring was consistent with our visual observations,
made while performing BALF collection, that IL-33KO/Tg+ mice
contained relatively larger mucus plugs (data not shown).
Increased mucous cell density (i.e., MCM) is a hallmark feature
of Tg+ lung disease (15). To explore whether the sustained mucus
obstruction in IL-33KO/Tg+ mice results from increased mucous
cell density, AB-PAS–stained lung sections were examined
for intracellular mucopolysaccharide contents. AB-PAS–stained
airway epithelial cells were sporadically present in the airways of
IL-33HET/WT but not in IL-33KO/WT mice (Fig. 4B). Although
the IL-33HET/Tg+ airway epithelium had significantly higher numbers
of AB-PAS–stained cells (Fig. 4B, 4C), the proportion of mucous cells
was significantly reduced in IL-33KO/Tg+ mice (Fig. 4B, 4D).
Absence of IL-33 has differential effect on the gene and protein
expression of gel-forming mucins
To determine the effect of IL-33 deletion on gene expression of two
major gel-forming mucins, Muc5b and Muc5ac, gene expression
analyses was performed on total RNA from lungs. As reported
previously (16), the Muc5b gene signatures were elevated in the
IL-33HET/Tg+ lungs (Fig. 5A). However, there was no significant
difference in the Muc5b gene signatures in IL-33HET/Tg+ versus
IL-33KO/Tg+ mice (Fig. 5A). As compared with WT counterparts,
IL-33HET/Tg+ and IL-33KO/Tg+ mice had significantly elevated
Muc5ac gene signatures (Fig. 5B). Although trending toward
lower expression, the reduction in Muc5ac gene signature in
IL-33KO/Tg+ mice did not reach statistical significance (Fig. 5B).
In addition, we performed in situ hybridization for the airway
epithelium-specific expression patterns of Muc5b and Muc5ac
transcripts. Both Muc5b and Muc5ac transcripts were almost equally
abundant in the epithelial cells of large airways of IL-33HET/Tg+
(Fig. 5C) as well as IL-33KO/Tg+ (Fig. 5D) mice.
To explore the effect of IL-33 deletion on protein contents of
both MUC5B and MUC5AC, their levels were determined in
BALF. MUC5B levels were very low and comparable between
IL-33HET/WT and IL-33KO/WT mice. As compared with their
WT counterparts, the IL-33HET/Tg+ and IL-33KO/Tg+ mice had
∼9- and 12-fold higher MUC5B content, respectively. Although
trending toward lower levels, the MUC5B contents in IL-33KO/Tg+
mice were not significantly lower than IL-33HET/Tg+ mice (Fig. 5E,
left panel, Supplemental Fig. 2A). MUC5AC BALF contents were
present at very low levels in the IL-33HET/WTas well as IL-33KO/WT
mice but were found to be significantly elevated in IL-33HET/Tg+
mice (Fig. 5F, right panel, Supplemental Fig. 2B). Importantly, as
compared with IL-33HET/Tg+ mice, the MUC5AC levels were
significantly reduced to the baseline levels in IL-33KO/Tg+ mice
(Fig. 5F, right panel, Supplemental Fig. 2B).
Absence of IL-33 does not alter postnatal mortality, body
weight, and prevalence of spontaneous bacterial infections in
Tg+ offspring
The Tg+ mice on C57BL/6 background exhibit mortality within
first 3 wk of postnatal life (13). To explore the contribution of
IL-33 toward postnatal mortality in Tg+ mice, we observed pups
from various breeding strategies (see Materials and Methods section)
for any postnatal distress and mortality. Pups of all the four
genotypes were born at expected Mendelian ratios, and as in-
dicated by their body weights at the age of 3 wk, none of the
offspring exhibited any signs of distress due to IL-33 deficiency
(Supplemental Fig. 3A). Whereas ∼19% IL-33HET/Tg+ pups did
not survive beyond 3 wk of age, IL-33KO/Tg+ pups exhibited a
nonsignificant increase (∼23%) in mortality (Supplemental Fig. 3B).
The status of IL-33 deficiency or Tg+ presence in parents undergoing
reciprocal crossings had no obvious effect on the postnatal
survival or body weights.
Table I. BALF cytokine levels (picograms per milliliter)
Cytokine IL-33HET/WT IL-33KO/WT IL-33HET/Tg+ IL-33KO/Tg+ LOD
IL-4 10.4 6 0.18 # 10.5 6 0.46 p 22.17 6 4.96 # p 11.56 6 0.50 3.2
IL-5 13.88 6 0.2# 14.1 6 0.4 p 42.4 6 16.0 # p 14.4 6 0.3 3.2
RANTES 26.3 6 0.5# 24.9 6 0.7 p 30.1 6 1.1# p 26.6 6 0.8 3.2
MIP1a 9.25 6 0.3 # F 10.1 6 0.3 p u 46.9 6 8.9 # p 26.7 6 2.7 F u 3.2
IP10 34.6 6 1.9 # F 38.1 6 2.1 p u 86.4 6 15.2 # p 52.5 6 5.4 F u 3.2
MIP1b 31.0 6 0.9 # F 31.2 6 0.8 p u 85.0 6 13.6 # p 64.6 6 6.5 F u 3.2
IL-12 (P70) 26.6 6 1.0 # 23.3 6 0.9 p 25.4 6 1.0 # p 23.3 6 0.9 3.2
KC 16.6 6 0.8 # F 18.3 6 0.9 p u 844.7 6 148.0 # p 623.6 6 170.1 F u 3.2
IL-6 11.8 6 0.4 # 12.1 6 0.5 p u 53.8 6 32.6 # p 29.1 6 8.7 u 3.2
TNF-a 15.3 6 0.4 # F 15.3 6 0.3 p u 28.1 6 2.4 # p 23.6 6 1.4 F u 3.2
MIP2 14.6 6 0.4 # F 14.8 6 0.2 p u 1282.0 6 665.8 # p 893.3 6 495.3 F u 3.2
G-CSF 16.9 6 0.5 # F 14.6 6 0.5 p u 1166.0 6 507.6 # p 727.1 6 171.1 F u 3.2
IL-17 16.4 6 0.3 # F 15.3 6 0.5 p u 22.4 6 2.8 # p 18.0 6 0.6 F u 3.2
IL-10 16.4 6 0.8 # 15.5 6 0.5 15.1 6 0.5 14.0 6 0.6 # 3.2
MCP1 10.2 6 0.4 # 10.2 6 0.3 p 11.61 6 0.5 # p 11.4 6 0.3 3.2
IL-2 18.9 6 1.1 # F 20.2 6 1.9 p u 14.3 6 1.1 # p 13.2 6 0.9 F u 3.2
IL-9 19.5 6 1.0 # F 20.5 6 1.6 p u 16.4 6 1.2 # p 15.2 6 0.5 F u 3.2
IL-1a 24.9 6 2.3 26.5 6 2.8 34.2 6 4.4 27.5 6 2.6 3.2
IL-1b 9.4 6 0.3 9.5 6 0.3 10.8 6 0.6 9.8 6 0.2 3.2
IFN-g 24.3 6 0.5 22.6 6 0.6 25.0 6 1.4 22.7 6 0.8 3.2
IL-7 21.3 6 0.7 18.9 6 0.6 20.0 6 0.8 20.2 6 1.1 3.2
IL-12 (P40) 26.6 6 1.0 23.3 6 0.9 25.4 6 1.0 23.3 6 0.9 3.2
Values bearing identical designations (# or p or F or u) within a row represent significant differences. Values in bold are significantly lower than those of the IL-33HET/Tg+
group ( n = 8–10). p # 0.05.
LOD, lowest limit of detection.
To determine the effect of IL-33 deletion on bacterial clearance,
we analyzed bacterial burden in aseptically collected BALF from
neonates (PND 7) and juveniles (PND 21). In the absence of
Scnn1b transgene, only 1 out of 10 IL-33HET/WT (CFU ∼3500)
and 3 out of 16 IL-33KO/WT (mean CFU ∼125.96 85.3) neonates
had bacterial infection (Supplemental Fig. 3C). As compared with
their WT counterparts, IL-33HET/Tg+ and IL-33KO/Tg+ neonates
had a significantly higher degree of bacterial infection. Only 1 out
of 12 IL-33HET/Tg+ and 4 out of 14 IL-33KO/Tg+ neonates had
no signs of bacterial infection. Mean CFU counts in IL-33HET/Tg+
(mean CFU ∼6.93 104 6 3.73 104) were not significantly different
from IL-33KO/Tg+ neonates (mean CFU ∼6.1 3 104 6 2.9 3 104)
(Supplemental Fig. 3C).
Tg+ mice are known to clear airspace infection by the age of 3 wk
(11). Only mild bacterial infection was detected in 7 out of 29
IL-33HET/WT (mean CFU ∼16.6 6 8.5) and 7 out of 16 IL-33KO/WT
(mean CFU ∼11.26 3.8) juveniles (Supplemental Fig. 3D). In contrast,
bacterial burden was significantly elevated in both IL-33HET/Tg+ (mean
CFU ∼443.2 6 231.4) and IL-33KO/Tg+ (mean CFU ∼59.4 6 24.9)
juveniles (Supplemental Fig. 3D). Although mean CFU counts were
trending toward lower in IL-33KO/Tg+ juveniles, the differences
between IL-33KO/Tg+ and IL-33HET/Tg+ juveniles were statisti-
cally nonsignificant (p = 0.12) (Supplemental Fig. 3D).
IL-33 deletion modulates pulmonary pathology in Tg+ juveniles
The effects of IL-33 deletion on Tg+ pulmonary pathology,
including airway inflammation, alveolar space enlargement, and
lymphoid hyperplasia, were examined. Subepithelial/peribronchiolar
airway inflammation with marked leukocytic infiltration is as-
sociated with Tg+ lung pathology (15). The airway inflamma-
tion was not evident in IL-33HET/WT as well as IL-33KO/WT
groups. As previously reported (15), the peribronchiolar in-
flammation was present in IL-33HET/Tg+ lungs (Fig. 6A). The
inflammatory cellular infiltrates were an admixture of neutro-
phils, eosinophils, and lymphocytes (Fig. 6A). In contrast, the
degree of neutrophilic and lymphocytic infiltration was signifi-
cantly higher in IL-33KO/Tg+ lungs (Fig. 6A). As reflected by
the absence of eosinophils in IL-33KO/Tg+ BALF, the peri-
bronchiolar inflammation had negligible presence of eosinophils
(Fig. 6A).
Alveolar space enlargement is a consistent feature of Tg+ lung
disease (15). We performed semiquantitative (Fig. 6B; top) as well
FIGURE 3. IL-33 deficiency suppresses 
molecular markers of Th2 inflammation 
in juvenile Tg+ lungs. Cytokine levels 
(picograms per milliliter) of IL-5 (A) 
and IL-4 (B) in cell-free BALF from 
IL-33HET/WT (white bar), IL-33KO/WT (blue 
bar), IL-33HET/Tg+ (green bar), IL-33KO/Tg+ 
juveniles (red bar). Error bars represent SEM. 
Absolute quantification (mRNA copies per 
1 3 105 copies of Actb mRNA) of mRNA  
for Slc26a4 (C), Clca1 (D), Retnla (E), 
and Chi3l4 (F) in lung homogenate of  
IL-33HET/WT (white bar), IL-33KO/WT 
(blue bar), IL-33HET/Tg+ (green bar), and 
IL-33KO/Tg+ juveniles (red bar). Error bars 
represent SEM. *p , 0.05, **p , 0.01 
using ANOVA followed by Tukey multiple 
comparison post hoc test.
as quantitative (MLI) analyses (Fig. 6B; bottom) on lung sections.
Both IL-33HET/WT and IL-33KO/WT had comparable alveolar
space sizes (Fig. 6B). As expected, alveolar space enlargement was
a prominent feature of the IL-33HET/Tg+ lungs but was widespread
and significantly greater in IL-33KO/Tg+ lungs (Fig. 6B).
Lymphoid hyperplasia (i.e., the appearance of lymphoid
aggregates/nodules) is another pathological response present in
Tg+ lungs (17, 18). Both IL-33HET/WT and IL-33KO/WT were
completely devoid of lymphoid aggregates. Although 5 out of
12 IL-33HET/Tg+ lungs had lymphoid aggregates, 9 out of 14
IL-33KO/Tg+ mice had greater incidence of lymphoid aggregates
with greater numbers per animal (Fig. 6C). However, this increase
in prevalence of lymphoid aggregates in IL-33KO/Tg+ mice was
not statistically significant (p = 0.15).
Discussion
Our recent report demonstrated a positive correlation between
increased levels of IL-33 in the muco-obstructive airspaces of Tg+
mice and robust MCM (9). Both responses were found suppressed
in the secondhand smoke (SHS)–exposed Tg+ juveniles (9). Ac-
cordingly, we had proposed in our conceptual model that the ASL
dehydration triggers IL-33 release from airway epithelial cells
that, via downstream effector cells, orchestrate MCM in Tg+
airways (9). In addition, we conceptualized that the SHS exposure
results in the suppression of IL-33 expression in airway epithelial
cells that eventually leads to the suppression of MCM. This model
led us to the next logical step of investigating the effect of
germline deletion of IL-33 on the MCM and MCM-associated
pathological features such as mucus obstruction, airway inflam-
mation, and bacterial infection. In the current study, employing
the IL-33KO/Tg+ mouse, we have mechanistically tested our
central hypothesis that IL-33 is essential for Th2 inflammatory
responses that contribute to the mucus obstruction in the airways
of Tg+ mice.
The Tg+ lung disease follows a typical age-associated shift in
inflammatory milieu in the airspaces that alters activation patterns
of macrophages (16). Whereas M1 activation, a Th1-associated
classical macrophage activation pattern, predominates in Tg+ at
PND 3, the M2 activation, Th2-associated alternative macrophage
activation, is robust at PND 10 and PND 42 (16). This trend likely
suggests that the Th1 response that coincides with the onset of
spontaneous bacterial infection is switched to Th2 responses during
the second week of age. The levels of IL-33, a primary Th2 re-
sponse trigger, in Tg+ BALF confirm this correlation (i.e., absence
of detectable IL-33 at PND 7 and significant presence of IL-33 at
PND 21) (Fig. 1A). These data suggest that release of IL-33 into
the airspaces, which occurs sometime between PND 7 and PND
21, likely mirrors Th2 responses in Tg+ mice.
Upon allergen challenge, stressed epithelial cells release IL-33
that, along with IL-25 and TSLP, initiates Th2-predominated
responses (19). The identity of trigger for IL-33 release in Tg+
airspaces remains unclear. Although ASL dehydration along with
FIGURE 4. IL-33 deletion does not al-
leviate mucus obstruction despite signif-
icant suppression of mucous cell density
in juvenile Tg+ airways. (A) Semiquanti-
tative histological scoring for airway mucus
obstruction in IL-33HET/WT (white bar),
IL-33KO/WT (blue bar), IL-33HET/Tg+ (green
bar), and IL-33KO/Tg+ juveniles (red bar).
(B) Number of mucous cells per millimeter
of basement membrane, IL-33HET/WT (white
bar), IL-33KO/WT (blue bar), IL-33HET/Tg+
(green bar), and IL-33KO/Tg+ juveniles (red
bar). (C) Representative photomicrograph
of AB-PAS–stained left lung section from
IL-33HET/Tg+ (higher magnification of inset
is shown as dotted green border). Intracellular
AB-PAS staining of mucous cells is indicated
by red arrows. (D) Representative photomi-
crograph of AB-PAS–stained left lung section
from IL-33KO/Tg+ (higher magnification
of inset is shown as dotted red border).
Error bars represent SEM. **p , 0.01,
****p, 0.0001 using ANOVA followed by
Tukey multiple comparison post hoc test.
epithelial necrosis is evident well before PND 5 (15), the BALF
from 7-d-old Tg+ pups did not show any evidence of IL-33
(Fig. 1A). It is likely that epithelial necrosis, a response seen
during early neonatal stage (15), initiates IL-33 release from necrotic
cells that achieve measurable concentration somewhere between
PND 7 and PND 21. In contrast, because alveolar epithelial cells
in Tg+ mice stained intensely for nuclear IL-33, the possibility
exists that alveolar epithelial cells are the primary source of BALF
IL-33 (Fig. 1B). Further studies using Tg+ mice with cell-specific
(e.g., airway epithelium, alveolar epithelium, and immune cells)
ablation of IL-33 are required to identify the cellular source of
IL-33 in Tg+ mice.
In our recent report, mucus obstruction was significantly reduced
in the SHS-exposed Tg+ mice (9). Strong association of this out-
come with suppressed IL-33 expression and diminished MCM in
the SHS-exposed Tg+ mice led to our hypothesis that the mucus
obstruction would be significantly reduced in the absence of mu-
cous cells in IL-33KO/Tg+ lungs. Counterintuitively, our data reveal
that the complete absence of mucous cells does not alleviate mucus
obstruction from Tg+ airways (Fig. 4A–D). In other words, reten-
tion of ciliated cell density does not restore normal ciliary clearance
function as well. It is therefore most likely that the accumulation
of normally produced mucopolysaccharides in the dehydrated
ASL layer of Tg+ mice, rather than increased mucous cell density,
contributes to the pathologic mucus obstruction in Tg+ mice.
Our mRNA copy number analyses (RT-PCR–based gene
expression and in situ RNA hybridization analyses) revealed
that IL-33HET/Tg+ as well as IL-33KO/Tg+ mice had comparable
copy numbers for Muc5b (Fig. 5A, 5C, 5D). Further, MUC5B
protein contents were also not significantly different in the BALF
FIGURE 5. IL-33 deletion results in re-
duced MUC5AC but not MUC5B protein 
contents in juvenile Tg+ BALF. Absolute 
quantification (mRNA copies per 1 3 105 
copies of Actb mRNA) of mRNA for Muc5b 
(A)  and Muc5ac (B) in lung homogenate of 
IL-33HET/WT (white bar), IL-33KO/WT (blue 
bar), IL-33HET/Tg+ (green bar), IL-33KO/Tg+ 
(red bar) mice. Error bars represent SEM. 
*p , 0.05 using ANOVA followed by 
Tukey multiple comparison post hoc test. 
Representative photomicrograph from in 
situ mRNA hybridization (RNAScope) anal-
yses of Muc5b (green stain) and Muc5ac 
(red stain) transcripts in lung sections from 
IL-33HET/Tg+ (C) (higher magnification of 
inset is shown as dotted green border) and 
IL-33KO/Tg+ (D) (higher magnification of inset 
is shown as dotted red border) mice. Western 
blot analyses for MUC5B (E) and  MUC5AC
(F) in the BALF from IL-33HET/WT (white 
bar), IL-33KO/WT (blue bar), IL-33HET/Tg+ 
(green bar), IL-33KO/Tg+ (red bar) mice. 
Error bars represent SEM. Images used 
for the quantification of agarose Western 
blot for MUC5B and MUC5AC are sup-
plied as Supplemental Fig. 2. **p , 0.01, 
***p , 0.001 using ANOVA followed by 
Tukey multiple comparison post hoc test.
from IL-33HET/Tg+ as well as IL-33KO/Tg+ mice (Fig. 5E). In
contrast, although the Muc5ac copy number was trending lower in
IL-33KO/Tg+ mice versus IL-33HET/Tg+ mice (Fig. 5B), the MUC5AC
protein contents were significantly lower in IL-33KO/Tg+ mice
versus IL-33HET/Tg+ mice (Fig. 5F). The positive correlations
between increased MUC5B, not MUC5AC, protein contents and the
mucus obstruction have been recently reported (20). In this study, the
complete loss of MUC5B (Muc5b2/2/Tg+) resulted in significant
reduction in the degree of mucus obstruction in Tg+ mice (20).
However, the loss of MUC5AC (Muc5ac2/2/Tg+) did not significantly
FIGURE 6. IL-33 deficiency modulates pulmonary pathology in Tg+ juveniles. (A) Semiquantitative histological scoring for airway inflammation in
IL-33HET/WT (white bar), IL-33KO/WT (blue bar), IL-33HET/Tg+ (green bar), and IL-33KO/Tg+ juveniles (red bar). Representative photomicrographs from
H&E-stained left lung lobe sections showing peribronchiolar inflammation in IL-33HET/Tg+ (left panel) and IL-33KO/Tg+ juveniles (right panel). Green and
red arrows point to neutrophils and eosinophils, respectively. (B) Semiquantitative histological scoring (top bar graph) for alveolar space enlargement in
IL-33HET/WT (white bar), IL-33KO/WT (blue bar), IL-33HET/Tg+ (green bar), and IL-33KO/Tg+ juveniles (red bar). Quantitative histological scoring
(bottom bar graph) for MLI in IL-33HET/WT (white bar), IL-33KO/WT (blue bar), IL-33HET/Tg+ (green bar), and IL-33KO/Tg+ juveniles (red bar).
Representative photomicrographs from H&E-stained left lung lobe sections from IL-33HET/WT (black border), IL-33KO/WT (blue border), IL-33HET/Tg+
(green border) and IL-33KO/Tg+ juveniles (red border). (C) Semiquantitative histological scoring for lymphoid hyperplasia in IL-33HET/WT (white bar),
IL-33KO/WT (blue bar), IL-33HET/Tg+ (green bar), IL-33KO/Tg+ juveniles (red bar). Representative photomicrographs from H&E-stained left lung lobe
sections showing lymphoid hyperplasia (black arrow) in IL-33HET/Tg+ (left panel) and IL-33KO/Tg+ juveniles (right panel). Error bars represent SEM.
*p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.000 using ANOVA followed by Tukey multiple comparison post hoc test.
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reduce the mucus obstruction in Tg+ mice (20). Along the same 
lines, although the IL-33KO/Tg+ mice still had high MUC5B 
contents (Fig. 5E), the mucus obstruction was not alleviated despite 
significant reduction in MUC5AC protein contents (Fig. 5F). These 
data suggest that IL-33 does not regulate the transcription or transla-
tion of Muc5b mucin. It seems plausible that IL-33–independent 
pathways, including the recently implicated IL-1R–mediated pathway 
(21, 22), may regulate the expression of Muc5b in Tg+ mice.
IL-33 has been shown to increase neutrophil recruitment in response 
to bacterial infections (23, 24). In this study, we report that neutrophil 
counts and the levels of key neutrophil chemoattractants, such as KC,
G-CSF, and MIP2, remain comparable between IL-33KO/Tg+ and 
IL-33HET/Tg+ BALF. These data suggest that IL-33–independent 
mechanisms are self-sufficient in neutrophil recruitment in response 
to spontaneous bacterial infections in Tg+ mice.
It has been shown that ILC2-derived IL-5 and IL-13 are essential 
for eosinophil recruitment, the deletion of IL-33R (ST2), however, 
does not completely inhibit eosinophil recruitment (25). In a recent 
report, Verma et al. (26) reported the existence of IL-13–expressing 
ILC2 in mice lacking ST2. These findings suggest the possible 
existence of IL-33–independent mechanisms for eosinophil 
recruitment whereby ILC2-derived IL-13 may induce eosinophil 
recruitment. However, eosinophil recruitment into Tg+ airways 
was abolished in the absence of IL-33 (i.e., scarce eosinophils 
were found only in 3 out of 14 IL-33KO/Tg+ mice). These data 
suggest that the eosinophil recruitment to the Tg+ airways occurs 
via IL-33–responsive ILC2s.
The ASL dehydration in Tg+ is strongly associated with 
alveolar space enlargement (15). The IL-33KO/Tg+ mice had 
significantly greater alveolar space enlargement, suggesting a 
protective role for IL-33 in this outcome. Two distinct cell-specific 
proteases, macrophage-specific matrix metalloproteinase 12 (MMP12) 
and neutrophil-specific neutrophil elastase (NE), have been impli-
cated in the alveolar space enlargement response (27, 28). However, 
both neutrophil and macrophage counts in IL-33HET/Tg+ and 
IL-33KO/Tg+ mice were comparable. Because alveolar epithelial 
cells in IL-33HET/Tg+ have upregulated expression of IL-33, it is 
possible that the loss of IL-33 in these cells make them susceptible 
to the alveolar space enlargement. Further studies are required 
to elucidate the mechanism by which IL-33 provides protection 
against excessive alveolar space enlargement.
In conclusion, this study revealed various findings on the in-
volvement of IL-33 in the manifestation of muco-obstructive lung 
disease in Tg+ mice. First, IL-33 is essential for the recruitment of 
eosinophils in the airspaces of Tg+ mice. Second, the deletion of 
IL-33 results in the suppression of molecular markers of Th2 in-
flammation in the Tg+ mice. Third, IL-33 is not essential for the 
transcription of Muc5b and Muc5ac genes; the translation of 
MUC5AC, however, is suppressed in the absence of IL-33. Fourth, 
although IL-33 deletion results in a significant reduction in mu-
cous cell density, the mucus obstruction remains persistent in the 
Tg+ mice. Consequently, the postnatal mortality and bacterial 
infection remained persistent in the Tg+ mice. Finally, IL-33 provides 
protection against exaggerated airway inflammation and alveolar 
space enlargement. These findings indicate that deletion of IL-33 
suppresses Th2 responses but fails to correct MUC5B hyper-
concentration and associated mucus obstruction in Tg+ airways. 
It remains unclear whether the MUC5B hyperconcentration and 
mucus obstruction are caused solely by the ASL dehydration or 
via IL-33–independent pathways.
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